LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

Abroad (travel likely)RecruitingPHASE2

Conditions

Nasopharyngeal Cancinoma (NPC) · Nasopharangeal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Jun Ma, vice president) · majun2@mail.sysu.edu.cn · +862087343469
Contact: Principal Investigator (Jun Ma, Professor)
Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China
Contact: Study coordinator (Yan-Ling Wu) · wuyl1202@163.com · 0755-66618168

Study leads

Jun Ma, M.D.
Principal Investigator
Sun Yat-sen University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Nasopharyngeal Cancinoma (NPC) · Recurrent Nasopharynx Carcinoma · Metastatic Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Guangzhou, China

Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Cancinoma (NPC)

Abroad (travel likely)RecruitingPHASE2

Dongguan, China · Guangzhou, China

QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.

Nasopharyngeal Cancinoma (NPC) · Nasopharyngeal Cancer

Abroad (travel likely)RecruitingPHASE3

Fuzhou, China · Dongguan, China

LDRT and Chemoimmunotherapy in NPC With Liver Metastasis

Nasopharyngeal Cancinoma (NPC)

Abroad (travel likely)RecruitingPHASE2

Changsha, China · Changsha, China